Publicaciones en las que colabora con Clara Bueno Uroz (21)

2024

  1. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

2023

  1. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency

    Haematologica, Vol. 108, Núm. 9, pp. 2551-2557

2022

  1. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Blood, Vol. 140, Núm. 1, pp. 38-44

  2. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

2012

  1. Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4 and MLL-germline acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 11, pp. 2360-2366

2009

  1. Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia

    Leukemia Research, Vol. 33, Núm. 7, pp. 980-990

2008

  1. NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: Is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?

    Leukemia

2005

  1. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361

2004

  1. A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation

    Laboratory Investigation, Vol. 84, Núm. 10, pp. 1387-1398

  2. Incidence and characteristics of CD4+/HLA DRhi dendritic cell malignancies

    Haematologica, Vol. 89, Núm. 1, pp. 58-69

  3. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation

    Leukemia, Vol. 18, Núm. 3, pp. 491-498

2003

  1. Flow cytometric analysis of cytokine responses in stimulated whole blood: simultaneous quantitation of TNF-alpha-secreting cells and soluble cytokines.

    Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.], Vol. Chapter 9

  2. TCRαβ+/CD4+ large granular lymphocytosis: A new clonal T-cell lymphoproliferative disorder

    American Journal of Pathology, Vol. 163, Núm. 2, pp. 763-771

2002

  1. A new method for detecting TNF-α-secreting cells using direct-immunofluorescence surface membrane stainings

    Journal of Immunological Methods, Vol. 264, Núm. 1-2, pp. 77-87

2001

  1. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage-/CD16+/HLA-DR+/CD14-/Io cells, CD14+ monocytes, and CD16- dendritic cells

    Clinical Immunology, Vol. 100, Núm. 3, pp. 325-338

  2. Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: Comparative analysis of different stimuli, secretion-blocking agents and incubation periods

    Communications in Clinical Cytometry, Vol. 46, Núm. 1, pp. 33-40

  3. Immunophenotypic identification, enumeration, and characterization of human peripheral blood dendritic cells and dendritic-cell precursors.

    Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.], Vol. Chapter 6

  4. Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide

    Leukemia, Vol. 15, Núm. 3, pp. 430-439

2000

  1. Cytoplasmic cytokines in the T cells of chronic alcoholics

    Alcoholism: Clinical and Experimental Research

  2. Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide

    Blood, Vol. 96, Núm. 11 PART II